[HTML][HTML] Pharmacogenomics of cytochrome P450 3A4: recent progress toward the “missing heritability” problem

K Klein, UM Zanger - Frontiers in genetics, 2013 - frontiersin.org
CYP3A4 is the most important drug metabolizing enzyme in adult humans because of its
prominent expression in liver and gut and because of its broad substrate specificity, which …

Activation/inactivation of anticancer drugs by CYP3A4: influencing factors for personalized cancer therapy

F Wang, X Zhang, Y Wang, Y Chen, H Lu… - Drug Metabolism and …, 2023 - ASPET
Cytochrome P450 3A4 (CYP3A4), one of the most important members of the cytochrome
P450 subfamily, is a crucial catalyst in the metabolism of numerous drugs. As it catalyzes …

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy

CA Altar, J Hornberger, A Shewade… - International review of …, 2013 - Taylor & Francis
Adverse events, response failures and medication non-compliance are common in patients
receiving medications for the treatment of mental illnesses. A systematic literature review …

Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population

GX Hu, DP Dai, H Wang, XX Huang, XY Zhou… - …, 2017 - Future Medicine
Aim: To systematically investigate the genetic polymorphisms of the CYP3A4 gene in a Han
Chinese population. Materials & methods: The promoter and exons of CYP3A4 gene in …

[HTML][HTML] Reviewing pharmacogenetics to advance precision medicine for opioids

L Magarbeh, I Gorbovskaya, B Le Foll, R Jhirad… - Biomedicine & …, 2021 - Elsevier
Background Adequate opioid prescribing is critical for therapeutic success of pain
management. Despite the widespread use of opioids, optimized opioid therapy remains …

[HTML][HTML] Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A …

BB Dennis, M Bawor, L Thabane, Z Sohani, Z Samaan - PloS one, 2014 - journals.plos.org
Background Genetic variability may influence methadone metabolism, dose requirements,
and risk of relapse. Objectives To determine whether the CYP2B6* 6 or ABCB1 (rs1045642) …

Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population

W Zhao, H Meng - Bioengineered, 2022 - Taylor & Francis
As a chronic brain disease, epilepsy affects~ 50 million people worldwide. The traditional
antiepileptic drugs (AEDs) are widely applied but showing various problems. Although the …

Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient

N Vadivelu, S Mitra, AD Kaye, RD Urman - Best practice & research …, 2014 - Elsevier
The epidemic use of illicit drugs has led to an increasing number of patients with drug
addiction and dependence presenting for perioperative care. There are a wide variety of …

[HTML][HTML] Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L …

HC Yang, SK Chu, CL Huang, HW Kuo, SC Wang… - PLoS …, 2016 - journals.plos.org
Methadone maintenance treatment (MMT) is commonly used for controlling opioid
dependence, preventing withdrawal symptoms, and improving the quality of life of heroin …

[HTML][HTML] Cannabis pharmacogenomics: a path to personalized medicine

M Babayeva, ZG Loewy - Current Issues in Molecular Biology, 2023 - mdpi.com
Cannabis and related compounds have created significant research interest as a promising
therapy in many disorders. However, the individual therapeutic effects of cannabinoids and …